Search Results - "Verhelst, Johan"

Refine Results
  1. 1

    Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients by Delgrange, Etienne, Daems, Tania, Verhelst, Johan, Abs, Roger, Maiter, Dominique

    Published in European journal of endocrinology (01-05-2009)
    “…ContextMacroprolactinomas poorly responsive to dopamine-agonists are often more aggressive and are usually termed ‘resistant’ but this clinical concept has…”
    Get full text
    Journal Article
  2. 2

    The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis by Verhelst, Johan, Mattsson, Anders F, Camacho-Hübner, Cecilia, Luger, Anton, Abs, Roger

    Published in Endocrine Connections (01-05-2018)
    “…Background Adult-onset growth hormone deficiency (AO-GHD) is associated with an increased prevalence of the metabolic syndrome (MetS). Aim To determine the…”
    Get full text
    Journal Article
  3. 3

    Endocrine Consequences of Long-Term Intrathecal Administration of Opioids by Abs, Roger, Verhelst, Johan, Maeyaert, Jan, Van Buyten, Jean-Pierre, Opsomer, Frank, Adriaensen, Hugo, Verlooy, Jan, Van Havenbergh, Tony, Smet, Mike, Van Acker, Kristien

    “…Intrathecal administration of opioids is a very efficient tool in the long-term control of intractable nonmalignant pain. However, despite the well known role…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Cabergoline in the Treatment of Acromegaly: A Study in 64 Patients by Abs, Roger, Verhelst, Johan, Maiter, Dominique, Van Acker, Kristien, Nobels, Frank, Coolens, Jean-Luc, Mahler, Charles, Beckers, Albert

    “…Cabergoline is a new, long acting, dopamine agonist that is more effective and better tolerated than bromocriptine in patients with hyperprolactinemia. Because…”
    Get full text
    Journal Article Web Resource
  6. 6

    Incidence of Diabetes Mellitus and Evolution of Glucose Parameters in Growth Hormone–Deficient Subjects During Growth Hormone Replacement Therapy by Luger, Anton, Mattsson, Anders F., KoŁtowska-Häggström, Maria, Thunander, Maria, Góth, Miklos, Verhelst, Johan, Abs, Roger

    Published in Diabetes care (01-01-2012)
    “…OBJECTIVE Growth hormone (GH) deficiency is associated with insulin resistance and diabetes. The aim of the current study was to determine incidence of…”
    Get full text
    Journal Article
  7. 7

    Long-term growth hormone replacement therapy in hypopituitary adults by VERHELST, Johan, ABS, Roger

    Published in Drugs (New York, N.Y.) (2002)
    “…Growth hormone deficiency (GHD) in the adult has now been fully recognised as a clinical entity characterised by abnormal body composition, osteopenia,…”
    Get full text
    Journal Article
  8. 8

    Remission of acromegaly following long-term therapy with cabergoline: report of two cases by Verhelst, Johan A., Abrams, Pascale J., Abs, Roger

    Published in Pituitary (01-03-2008)
    “…Dopamine agonists are effective in some patients with acromegaly and in this condition treatment is considered to be chronic. We describe two acromegalic…”
    Get full text
    Journal Article
  9. 9

    Cardiovascular risk factors in hypopituitary GH-deficient adults by Verhelst, Johan, Abs, Roger

    Published in European journal of endocrinology (01-11-2009)
    “…Design Data on lipids, body composition, and blood pressure (BP) from all published KIMS papers are summarized and compared with a literature review. Results…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Incidence of Diabetes Mellitus and Evolution of Glucose Parameters in Growth Hormone–Deficient Subjects During Growth Hormone Replacement Therapy: A long-term observational study by Luger, Anton, Mattsson, Anders F, KoŁtowska-Häggström, Maria, Thunander, Maria, Góth, Miklos, Verhelst, Johan, Abs, Roger

    Published in Diabetes care (01-01-2012)
    “…OBJECTIVE: Growth hormone (GH) deficiency is associated with insulin resistance and diabetes. The aim of the current study was to determine incidence of…”
    Get full text
    Journal Article
  12. 12

    Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement by Yuen, Kevin C J, Mattsson, Anders F, Burman, Pia, Erfurth, Eva-Marie, Camacho-Hubner, Cecilia, Fox, Janet L, Verhelst, Johan, Geffner, Mitchell E, Abs, Roger

    “…In adults, craniopharyngioma (CP) of either childhood-onset (CO-CP) or adult-onset (AO-CP) is associated with increased morbidity and mortality, but data on…”
    Get full text
    Journal Article
  13. 13

    Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis by Verhelst, Johan, Mattsson, Anders F, Luger, Anton, Thunander, Maria, Góth, Miklós I, Kołtowska-Häggström, Maria, Abs, Roger

    Published in European journal of endocrinology (01-12-2011)
    “…ObjectiveAn increased risk of cardiovascular morbidity and mortality in adult GH deficiency (GHD) may be related to hypopituitarism but also to the presence of…”
    Get full text
    Journal Article
  14. 14

    Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis by Abs, Roger, Mattsson, Anders F, Thunander, Maria, Verhelst, Johan, Góth, Miklós I, Wilton, Patrick, Kołtowska-Häggström, Maria, Luger, Anton

    Published in European journal of endocrinology (01-03-2013)
    “…ObjectiveGH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus…”
    Get full text
    Journal Article
  15. 15

    Corticotropin‐Dependent Cushing's Syndrome in Older People: Presentation of Five Cases and Therapeutical Use of Ketoconazole by Berwaerts, Joris J., Verhelst, Johan A., Verhaert, Griet C., Verhaegen, Ann A., Abs, Roger E.

    “…BACKGROUND: Cushing's syndrome is a rare disorder. The corticotropin (ACTH)‐dependent form of this syndrome generally results either from excessive ACTH…”
    Get full text
    Journal Article
  16. 16

    Active acromegaly is associated with decreased hs-CRP and NT-proBNP serum levels: insights from the Belgian registry of acromegaly by Verhelst, Johan, Velkeniers, Brigitte, Maiter, Dominique, Haentjens, Patrick, T'Sjoen, Guy, Rietzschel, Ernst, Corvilain, Bernard, Abrams, Pascale, Nobels, Frank, Abs, Roger, Bex, Marie

    Published in European journal of endocrinology (01-02-2013)
    “…ObjectivePatients with active acromegaly have an increased prevalence of cardiomyopathy and heart failure but a less than expected risk of coronary artery…”
    Get full text
    Journal Article
  17. 17

    Hyperprolactinemia: pathophysiology and management by Verhelst, Johan, Abs, Roger

    Published in Treatments in endocrinology (2003)
    “…Hyperprolactinemia is commonly found in both female and male patients with abnormal sexual and/or reproductive function or with galactorrhea. If serum…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Optimalization and cost management of lanreotide-Autogel therapy in acromegaly by Abrams, Pascale, Alexopoulou, Orsalia, Abs, Roger, Maiter, Dominique, Verhelst, Johan

    Published in European journal of endocrinology (01-11-2007)
    “…AbstractBackgroundLanreotide-Autogel is a depot formulation of the somatostatin analog lanreotide used in the treatment of acromegaly. We investigated whether…”
    Get full text
    Journal Article
  20. 20

    Hyperfunctioning metastatic follicular thyroid carcinoma in Pendred's syndrome by Abs, R, Verhelst, J, Schoofs, E, De Somer, E

    Published in Cancer (15-04-1991)
    “…A 66-year-old woman with Pendred's syndrome underwent a partial thyroidectomy when she was 17 years old. At the age of 52 years, she had a second thyroid…”
    Get more information
    Journal Article